Role of the Glucose Tolerance Test as a Predictor of Preeclampsia
Artículo
Publication date
2014Metadata
Show full item record
Cómo citar
Sepúlveda Martínez, Alvaro
Cómo citar
Role of the Glucose Tolerance Test as a Predictor of Preeclampsia
Author
Abstract
Objective: To determine whether oral glucose tolerance
tests (OGTT) play a role as predictors of preeclampsia (PET)
in pregnant women. Methods: A retrospective case-control
study was conducted in 2,002 singleton pregnancies that
had a uterine artery (UtA) Doppler at 22–25 weeks and an
OGTT. The UtA Doppler and OGTT were adjusted based on
maternal characteristics, and the results were expressed as
multiples of the expected normal median and compared between
groups. Logistic regression analysis was used to determine
whether maternal characteristics, OGTT, and UtA
Doppler significantly contribute to the prediction of early-
(<34 weeks), intermediate- (34–37 weeks), or late-onset (>37
weeks) PET. The performance of the screening was determined
by ROC curves. Results: Women who developed PET
were characterized by an older maternal age, an increased
body mass index, and an altered UtA Doppler. The group
with intermediate-onset PET was the only one associated
with higher 2-hour OGTT levels compared to controls. Combined
models were developed via logistic regression analysis
using maternal characteristics, UtA Doppler, and OGTT to
predict PET. These combined models were able to detect around 74, 42, and 21% of women who later developed early-,
intermediate-, or late-onset PET, respectively, with only a
5% false-positive rate. Conclusions: This study shows that
the combination of maternal characteristics, second-trimester
UtA Doppler, and OGTT is a predictor of the development
of PET in healthy pregnant women.
General note
Artículo de publicación ISI
Patrocinador
This study was supported by grants from FONDECYT (Fondo
Nacional de Ciencia e Investigación; No. 1090245 and 1130668).
We also wish to thank all students and collaborators from the Fetal
Medicine Unit, Obstetrics and Gynecology Department and Faculty
of Medicine, University of Chile Hospital, and in particular
Prof. Jeremy Pearson of King’s College London for his valuable
support in writing the manuscript.
Quote Item
Gynecol Obstet Invest 2014;78:130–135
Collections